We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Next-generation POC Devices for Western and Global Health Markets

Video   Jul 21, 2015

 



About the Speaker
Samuel Sia is an Associate Professor in the Department of Biomedical Engineering at Columbia University. His lab focuses on using microfluidics for global health diagnostics and for 3D tissue biology. He is a founder of Claros Diagnostics, a venture capital-backed company developing diagnostics products which was acquired by Opko Health, and Harlem Biospace, New York City's first life-science incubatorAbstract
Portable diagnostic devices have a tremendous potential for revolutionizing personal health.  In U.S. and Europe, patients and consumers can have greater access to traditionally complex diagnostics, and in developing countries, mobile diagnostics provides immediate diagnosis in the field.  We will discuss our lab's current efforts in these areas, in conjunction with partners in industry, public health, and local governments.  Our tests span a variety of technologies, and target HIV, sexually transmitted diseases, and chronic diseases.

 
 
 
 

Recommended Videos

A Cancer Campaign for the Lads| Rugby Star Raises Awareness

Video

Former Welsh rugby captain and testicular cancer survivor Matthew Rees urges men to "check their tackle."

WATCH NOW

From Biopsy to Diagnosis: How Pathologists Diagnose Cancer and Other Diseases

Video

This video provides a glimpse into the world of pathology by showing how pathologists and other laboratory professionals help to diagnose patients' biopsies. This behind-the-scenes look into the University of Michigan Department of Pathology shows how tissue is prepared to be viewed under a microscope and what pathologists are looking for in order to determine a diagnosis.

WATCH NOW

Biomarker-based Companion Diagnostics Are Enabling Precision Oncology

Video

Clinical trials are underway to examine the efficacy of various immune checkpoint inhibitor molecules, for the treatment of cancer. Watch this video to learn about the companion diagnostics that are enabling the identification of patients who could benefit from these treatments.

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE